News & Views
Lung cancer drug 'could prevent metastases spreading'
Feb 25 2011
Dr Michela Quirino and colleagues from the Catholic University of the Sacred Heart in Rome announced the laboratory news after investigating how zoledronic acid may be able to prevent the cancer from spreading.
Currently, the drug is used to help treat bone metastases but the study suggests it may also be useful in the initial stages of the disease.
Dr Quirino said: "If further studies should confirm a possible anti-metastatic effect of this drug ... it could be introduced in the early management of the disease, even as an adjuvant therapy."
The expert conducted a trial on 41 patients with advanced lung cancer and concluded that the evidence implies zoledronic acid may prevent the metastases from recruiting the blood vessels they need to survive.
Zoledronic acid is also used to treat high levels of calcium in the blood.
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan